Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Compliance Checklist: Covering Your Bases Whether youre prescribing GLP-1s or controlled substances via telehealth, heres your non-negotiable compliance checklist: Licensure & Platform [ ] Licensed in every state where patients are located [ ] Using HIPAA-compliant video platform [ ] Documented telehealth consent (required in CA, IL, recommended everywhere) [ ] E-prescribing system with EPCS certification (required in NY, CA, IL, TX for controlled substances) Patient Evaluation [ ] Live video exam (audio-only insufficient for initial weight-loss evaluation in most states) [ ] Documented weight/BMI and eligibility criteria (BMI 30 or 27 with comorbidities) [ ] Screening for contraindications (cardiovascular disease, pregnancy, eating disorders, thyroid issues) [ ] For controlled substances: PDMP check completed and documented [ ] For psychiatric patients: Assessment of how weight-loss meds might interact with psych medications Informed Consent & Documentation [ ] Written informed consent outlining risks, benefits, alternatives (required in FL, best practice everywhere) [ ] Documentation of diet/exercise counseling or referral (required in NJ, expected nationally) [ ] Treatment plan with follow-up schedule [ ] For FL providers: Weight-Loss Consumer Bill of Rights provided to patient Follow-Up & Monitoring [ ] Follow-up visits at least every 3 months (FL requirement
These were dysplastic naevi, which is an odd-looking, often large mole that is thankfully non-cancerous
They require a prescription and medical supervision
Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
A.SchranteeA.Ter HorstK
US$ 29.74
US$ 23.01
US$ 24.80
US$ 28.82
US$ 27.90
